From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Use of GLP-1 receptor agonists, which have shown to be effective in diabetes and obesity treatment, is expanding into other ...

GLP-1 receptor agonists mimic the action of the glucagon-like peptide-1 hormone, which is involved in the regulation of ...

Surging demand for Ozempic and other GLP-1 drugs is adding up for some Minnesota employers. Why it matters: The popular ...

Thousands of low-income Pennsylvanians will face new barriers to weight-loss drugs like Ozempic under a move quietly ...

GLP-1s for weight loss may not affect the risk of obesity-related cancers either way, an analysis of the existing evidence ...

As Americans prepare for Christmas, it’s safe to say there were plenty of jokes at family tables this year about the ...

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

Constellation Brands, Inc. (NYSE:STZ) ranks among the best sin stocks to buy in 2026. On November 21, Piper Sandler cut its ...

The study analyzed electronic health records from 708,406 patients diagnosed with breast cancer between January 2011 and ...